Notícias Bausch Health Companies Inc - BHC | Ações Toronto Stock Exchange | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
Canadá
TSX
Bausch Health Companies Inc (BHC)
Bausch Health Companies Inc (BHC) Notícias

Bausch Health Companies Inc (BHC)

11,39

0,29

(2,61%)

Fechado 27 Novembro 6:12PM

Atrasado por 15 minutos

Seu centro para cotações em tempo real, discussões ao vivo e novas ideias.

OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease

SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC PATIENT POPULATION

Seasonal Affective Disorder (SAD) Is Now a Recognized Diagnosis in the CMS Tabular Index, Accessible to Prescribers Oct. 1, 2022

SALIX PHARMACEUTICALS APPLAUDS IMPLEMENTATION OF K76.82 - A NEW ICD-10 CODE FOR HEPATIC ENCEPHALOPATHY

Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations

Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent Solicitations

Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin

Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent Solicitations

Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with Support from Approximately 23% of Outstanding Existing Senior Notes

Bausch Health Continuing Process Toward Separating Bausch + Lomb

Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit

Salix Supports CMS Announcement of First ICD-10 Code for Hepatic Encephalopathy (HE)

BAUSCH HEALTH ANNOUNCES SECOND-QUARTER 2022 RESULTS

Bausch Health Provides Update Following Oral Order in XIFAXAN® Patent Litigation

Bausch Health Companies Inc. Will Release Second-Quarter 2022 Financial Results on Aug. 9

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Bausch Health Companies

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições